Cargando…
Adoptive Cell Therapy for T-Cell Malignancies
SIMPLE SUMMARY: Patients with relapsed and refractory T-cell malignancies have poor outlook and limited treatment options. Recently, adoptive cell therapy has emerged as a promising therapy for patients with T-cell malignancies. In this review, we examine the current progress on adoptive cell therap...
Autores principales: | Fang, Karen Kai-Lin, Lee, Jong Bok, Zhang, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817702/ https://www.ncbi.nlm.nih.gov/pubmed/36612092 http://dx.doi.org/10.3390/cancers15010094 |
Ejemplares similares
-
State-of-Art of Cellular Therapy for Acute Leukemia
por: Lee, Jong-Bok, et al.
Publicado: (2021) -
A New Hope in Immunotherapy for Malignant Gliomas: Adoptive T Cell Transfer Therapy
por: Chung, Dong-Sup, et al.
Publicado: (2014) -
Adoptive T-cell therapy for Leukemia
por: Garber, Haven R, et al.
Publicado: (2014) -
CAR-T Cells Shoot for New Targets: Novel Approaches to Boost Adoptive Cell Therapy for B Cell-Derived Malignancies
por: Marhelava, Katsiaryna, et al.
Publicado: (2022) -
Challenges and new technologies in adoptive cell therapy
por: Zhang, Pengchao, et al.
Publicado: (2023)